PTC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of PTC Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $0.20 | $-1.14 | 117.5 % |
| Q2 | 2025-08-07 | $-0.83 | $-1.07 | 22.4 % |
| Q1 | 2025-05-06 | $10.04 | $-0.70 | 1534.3 % |
| Q4 | 2025-02-27 | $-0.85 | $-0.65 | -30.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $211.01M | $175.55M | 20.2 % |
| Q2 | 2025-08-07 | $178.88M | $172.68M | 3.59 % |
| Q1 | 2025-05-06 | $1.18B | $372.61M | 215.6 % |
| Q4 | 2025-02-27 | $213.17M | $248.99M | -14.4 % |
PTC Therapeutics (PTCT) is scheduled to report earnings on February 26, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
The Actual EPS was $0.20, which beat the estimate of $-1.14.
The Actual Revenue was $211M, which beat the estimate of $175.5M.
Browse earnings estimates, EPS, and revenue on all stocks.